Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

ConditionH. Pylori Infection

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age19+

SponsorSohag University

About this trial

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

Eligibility criteria

Qualifiers

Age: >18 years old.

H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).

Disqualifiers

Prior H. pylori treatment: Previous treatment for H. pylori infection.

Allergies: Known allergies to study medications or components.

Patients cannot finish treatment course.

Patient missed follow up.

Trial design

Treatments tested in this trial

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection
Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection
Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

Treatment groups

150 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Sohag University

Lead sponsor

Source ClinicalTrials.gov